Granules Life Sciences’ Hyderabad plant gets VAI inspection classification from U.S. FDA

The establishment inspection report (EIR) was issued following a current good manufacturing practice (cGMP) and pre-approval inspection (PAI) of the oral solid dosage manufacturing operations between December 15 and 19 The establishment inspection report (EIR) was issued following a current good manufacturing practice (cGMP) and pre-approval inspection…

Key takeaways

Quick scan — what you need to know:

• The establishment inspection report (EIR) was issued following a current good manufacturing practice (cGMP) and pre-approval inspection (PAI) of the oral solid dosage manufacturing operations…
• The establishment inspection report (EIR) was issued following a current good manufacturing practice (cGMP) and pre-approval
• inspection (PAI) of the oral solid dosage manufacturing operations between December 15 and 19 The establishment inspection report
• (EIR) was issued following a current good manufacturing practice (cGMP) and pre-approval inspection (PAI) of the oral solid dosage

Background

What led here, in plain terms:

• December 15 and 19 The establishment inspection report (EIR) was issued following a current good manufacturing practice (cGMP) and pre-approval inspection (PAI) of the oral solid dosage manufacturing operations between…
• Full context often emerges as officials, markets, or courts add updates.

Why it matters

Why readers and decision-makers should care:

• The establishment inspection report (EIR) was issued following a current good manufacturing practice (cGMP) and pre-approval
• inspection (PAI) of the oral solid dosage manufacturing operations between December 15 and 19 The establishment inspection report
• (EIR) was issued following a current good manufacturing practice (cGMP) and pre-approval inspection (PAI) of the oral solid dosage